Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADVM | DSGN | TRVI | ||
| Company | Adverum Biotechnologies Inc | Design Therapeutics Inc | Trevi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.11 | 3.69 | 2.89 | ||
| High | 10.15 | 3.70 | 3.05 | ||
| Low | 9.50 | 3.55 | 2.87 | ||
| Last | 10.00 | 3.65 | 3.01 | ||
| Change | +0.21 | +0.03 | +0.15 | ||
| % Change | +2.15% | +0.83% | +5.24% | ||
| Volume | 374,200 | 148,000 | 90,300 | ||
| 20-Day Average Volume | 322,340 | 270,925 | 178,390 | ||
| Previous Close | 9.79 | 3.62 | 2.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.00 | 3.73 | 2.84 | ||
| 20-Day Raw Stochastic | 26.72% | 29.63% | 77.64% | ||
| 20-Day Relative Strength | 34.82% | 53.69% | 53.63% | ||
| Weighted Alpha | -27.95 | +25.81 | -17.41 | ||
| Today's Opinion | 56% Sell | 72% Buy | 72% Buy | ||
| Previous Opinion | 56% Sell | 72% Buy | 56% Buy | ||
| Last Month's Opinion | 8% Buy | 56% Buy | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.50% since 04/25/24 | -2.93% since 04/25/24 | +18.50% since 04/25/24 | ||
| Low | 8.76 on 04/29/24 | 3.51 on 04/30/24 | 2.50 on 04/26/24 | ||
| High | 10.98 on 04/30/24 | 3.94 on 04/29/24 | 3.09 on 04/30/24 | ||
| 1-Month | |||||
| %Chg | -25.37% since 04/02/24 | -5.68% since 04/02/24 | -6.81% since 04/02/24 | ||
| Low | 8.76 on 04/29/24 | 3.45 on 04/10/24 | 2.35 on 04/17/24 | ||
| High | 14.16 on 04/04/24 | 4.13 on 04/17/24 | 3.25 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | -29.58% since 02/02/24 | +53.36% since 02/02/24 | +116.55% since 02/02/24 | ||
| Low | 8.76 on 04/29/24 | 2.24 on 02/13/24 | 1.38 on 02/05/24 | ||
| High | 29.70 on 02/08/24 | 4.14 on 04/01/24 | 4.00 on 03/21/24 | ||
| 6-Month | |||||
| %Chg | +3.01% since 11/02/23 | +74.64% since 11/02/23 | +81.33% since 11/02/23 | ||
| Low | 7.40 on 12/29/23 | 1.96 on 11/10/23 | 0.97 on 11/27/23 | ||
| High | 29.70 on 02/08/24 | 4.14 on 04/01/24 | 4.00 on 03/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,191 | 204,512 | 201,444 | ||
| Shares Outstanding, K | 20,755 | 56,495 | 70,435 | ||
| Annual Sales | 3,600,000 | 0 | 0 | ||
| Annual Net Income | -117,170,000 | -66,860,000 | -29,070,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -23,710,000 | -11,840,000 | -7,820,000 | ||
| 60-Month Beta | 0.89 | 1.83 | 0.91 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.30 on 03/18/24 | -0.21 on 03/19/24 | -0.08 on 03/20/24 | ||
| Latest Earnings Date | 05/09/24 | 05/14/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||